Safety and privacy |
Safety and risk |
Effectively assessing safety and risk |
|
|
Sensitive applications (e.g., military/dual use, malign use, manipulation) |
|
|
Particular sensitivity due to complexity and significance of the brain |
|
|
Particular sensitivity of using neurotechnologies with children |
|
Privacy |
Effective informed consent for data use / privacy concerns |
|
|
Use of repurposed data or unexpected future uses |
|
|
Reidentification |
|
|
Control of data; user ability to amend or delete |
|
|
Cultural differences in the importance and meaning of privacy |
Equity and justice |
Equity and |
Equitable distribution of new technologies and therapeutics |
|
distributive justice |
Equitable distribution of risks |
|
|
Diversity, inclusion, and avoidance of social/cultural bias in research |
|
|
Non-human animal research |
|
Discrimination and |
Protection from brain-data-based discrimination |
|
stigma |
Pressure to use enhancements |
|
|
Definitions of ‘normal’ and potential for stigma |
Agency, autonomy, |
Consent |
Meaningful informed consent |
and identity |
|
Continuing consent when using technologies that may alter the mind |
|
Manipulation |
Ability of neurotechnologies to manipulate people |
|
|
Limiting use in manipulative applications |
|
Human-ness |
Integrity of person |
|
|
Regard for donors of, e.g., brain tissue |
|
|
Moral significance of synthetically created neural systems |